1) Group A streptococcus preparation
A群链球菌制剂
1.
Treatment of 87 Cases of Giant Haemangioma with Group A Streptococcus Preparation(OK-432);
A群链球菌制剂治疗巨大海绵状血管瘤87例
2.
Objective To prepare Group A streptococcus preparation with the improved bouillon medium,and to study the LD50 and the anti-tumor activities of the preparation.
目的用改良培养基研制A群链球菌制剂,并研究其半数致死量(LD50)和抗肿瘤活性。
2) group A hemolytic streptococci
A群溶血性链球菌制剂
1.
Prevention of autoimmune diabetes by group A hemolytic streptococci in NOD mice
目的:研究A群溶血性链球菌制剂对NOD小鼠(自身免疫性糖尿病的动物模型)糖尿病的预防作用。
3) Sapyhin
A群链球菌冻干制剂
4) streptozotoein
链球菌制剂
1.
In order to explore the effect of streptozotoein on cytokines in splenocytes and serum of NOD mice,the effectiveness of streptozotoein on diabetes mellitus in mice model was studied.
为了探索链球菌制剂对NOD鼠脾细胞及血清细胞因子的影响,试验以NOD鼠为Ⅰ型糖尿病动物模型,在5～20周龄,皮下注射链球菌制剂,每只0。
5) Streptococcal Preparation SM
链球菌制剂SM
1.
The Inhibition of Various Tumor Cells Growth by Streptococcal Preparation SM;
链球菌制剂SM对不同肿瘤细胞生长的抑制作用
2.
The former were given Streptococcal preparation SM or PBS,respectively.
目的 探讨链球菌制剂SM对荷瘤小鼠红细胞免疫功能的影响。
3.
Objctive To study the tumor inhibory effect of a streptococcal preparation SM and it′s effect on mice′s immune organs.
结论 链球菌制剂SM具有明显的抑瘤效应 ,其作用与环磷酰胺相比无显著性差异 ,并有促进S180荷肉瘤小鼠免疫器官增生作用。
6) Streptococcal preparation
溶血链球菌制剂
补充资料：α-溶血性链球菌
α-溶血性链球菌
属链球菌属。因其菌落周围出现1～2mm宽的草绿色溶血环(甲型溶血），又称为草绿色链球菌。该菌为人呼吸道及肠道的正常寄生菌，致病力低，在一定条件下可引起亚急性细菌性心内膜炎及泌尿系感染。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条